Haleon (NYSE:HLN) Downgraded by Morgan Stanley to Equal Weight

Morgan Stanley lowered shares of Haleon (NYSE:HLN) from an overweight rating to an equal weight rating in a report released on Friday morning, Marketbeat reports.

Other analysts also recently issued research reports about the stock. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $10.95.

Haleon Price Performance

Shares of Haleon stock opened at $9.11 on Friday. The stock has a market capitalization of $41.24 billion, a P/E ratio of 26.79, a PEG ratio of 2.95 and a beta of 0.29. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The business’s fifty day moving average price is $9.61 and its 200 day moving average price is $9.67. Haleon has a twelve month low of $7.89 and a twelve month high of $10.80.

Institutional Investors Weigh In On Haleon

Several hedge funds have recently modified their holdings of the stock. FMR LLC grew its position in Haleon by 5.8% in the third quarter. FMR LLC now owns 104,918,269 shares of the company’s stock valued at $1,110,035,000 after acquiring an additional 5,768,117 shares in the last quarter. Clearbridge Investments LLC boosted its stake in shares of Haleon by 8.6% in the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock valued at $344,888,000 after purchasing an additional 3,307,009 shares during the period. Wellington Management Group LLP grew its holdings in Haleon by 49.9% during the 3rd quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock valued at $96,833,000 after purchasing an additional 3,046,841 shares in the last quarter. Sculptor Capital LP lifted its holdings in Haleon by 67.8% in the 2nd quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock worth $73,407,000 after buying an additional 3,592,000 shares in the last quarter. Finally, Douglas Lane & Associates LLC boosted its position in Haleon by 1.9% in the 4th quarter. Douglas Lane & Associates LLC now owns 8,624,149 shares of the company’s stock valued at $82,274,000 after buying an additional 161,865 shares during the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.